Dysphagia-optimised intensity-modulated radiotherapy versus standard radiotherapy in patients with pharyngeal cancer - Authors' reply

Lancet Oncol. 2023 Oct;24(10):e398. doi: 10.1016/S1470-2045(23)00457-6.

¹ Head and Neck Unit, The Royal Marsden Hospital, London, UK; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK. Electronic address: chris.nutting@rmh.nhs.uk.
² Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK.
³ Department of Speech, Voice and Swallowing, The Royal Marsden Hospital, London, UK; Department of Surgery and Cancer, Imperial College, London, UK.
⁴ Department of Oncology, Guys and St Thomas' Hospital, London, UK.
⁵ Northern Ireland Cancer Centre, Belfast City Hospital, Belfast, UK.

No abstract available

Publication types